Selected protein kinase inhibitors for the treatment of neurolog

Details Selected protein kinase inhibitors for the treatment of neurolog Selected protein kinase inhibitors for the treatment of neurolog

1993-07-22

1995-10-24

Datlow, Philip I.

Organic compounds -- part of the class 532-570 series

Organic compounds

Unsubstituted hydrocarbyl chain between the ring and the -c-...

548416, 514211, 514279, C07D49822, A61K 3155

Patent

active

054611466

ABSTRACT:
The invention features novel derivatives of K-252a, as well as novel bis-N-substituted derivatives of staurosporine. Also, a method for treating diseased neuronal cells involving the administration of either the novel staurosporine derivatives or specified functional derivatives of K-252a.

REFERENCES:
patent: 4554402 (1985-11-01), Hawkins et al.
patent: 4735939 (1988-04-01), McCoy et al.
patent: 4816450 (1989-03-01), Bell et al.
patent: 4877776 (1989-10-01), Murakata et al.
patent: 4923986 (1990-05-01), Murakata et al.
patent: 5093330 (1992-03-01), Caravatti et al.
Abe et al., Annals of the New York Academy of Sciences 559:259-268, 1989, "Arachidonic Acid Metabolism in Ischemic Neuronal Damage".
Borasio, Neuroscience Letters 108:207-212, 1990, "Differential Effects of the Protein Kinase Inhibitor K-252A on the in Vitro Survival of Chick Embyronic".
Davis et al., J. Med. Chem. 35:177-184, 1992, "Inhibitors of Protein Kinase C. 1.1 2,3 Bisarylmaleimides".
Davis et al., FEBS Letters 259:61-63, 1989, "Potent Selective Inhibitors of Protein Kinase C".
Hara et al., Journal of Cerebral Blood Flow and Metabolism 10:646-653, 1990, "Staurosporine, A Novel Protein Kinase C Inhibitor, Prevents Postischemic Neuronal Damage in the Gerbil and Rat".
Hashimoto, The Journal of Cell Biology 107:1531-1539, 1988, "K-252A, A Potent Protein Kinase Inhibitor, Blocks Nerve Growth Factor-Induced Neurite Outgrowth . . . in Phosphorylation of Proteins in PC12H Cells".
Kase et al., The Journal of Antibiotics 39:1059-6219, 1986, "K-252A, A Potent Inhibitor of Protein Kinase C from Microbial Origin".
Kiyoto et al., Biochem. and Biophys. Research Communications 148:740-746, 1987, "Staurosporine, A Potent Protein Kinase C Inhibitor, Fails to Inhibit 12-O-Tetradecanoylphorbol-13-Acetate Caused . . . Cells".
Knusel et al., Journal of Neurochemistry 57:955-961, 1991, "K-252B is a Selective and Monotoxic Inhibitor of Nerve Growth Factor Action on Cultured Brain Neurons".
Knusel et al., Journal of Neurochemistry 59:715-722, 1992, "K-252B Selectively Potentiates Cellular Actions and TRK Tyrosine Phosphorylation Mediated by Neurotropin-3".
Koizumi et al., The Journal of Neuroscience 8:715-721, 1988, "K-252A: A Specific Inhibitors of the Action of Nerve Growth Factor on PC12 Cells".
Lazarovici et al., Journal of Neuroscience Research 23:1-8, 1989, "K-252A Inhibits the Increase in C-FOS Transcription and the Increase in Intracellular Calcium Produced by Nerve Growth Factor in PC12 Cells".
Matsuda et al., Biochem J. 256:75-80, 1988, "The Effect of K-252A, A Potent Microbial Inhibitor of Protein Kinase, on Activated Cyclic Nucleotide Phosphodiesterase".
Moody et al., J. Org. Chem. 57:2105-2114, 1992, "Synthesis of the Staurosporine Aglycon".
Nabeshima et al., The Journal of Pharmacology and Experimental Therapeutics 257:562-566, 1991, "Staurosporine Facilitates Recovery from the Basal Forebrain-Lesion-Induced Impairment of . . . Neuron in Rats".
Nakadate et al., Biochemical Pharmacology 37:1541-1545, 1988, "Comparison of Protein Kinase C Functional Assays to Clarify Mechanisms of Inhibitor Action".
Nakanishi et al., The Journal of Antibiotics 39:1066-1071, 1986, "K-252B, C and D, Potent Inhibitors of Protein Kinase C from Microbial Origin".
Sako et al., Cancer Research 48:4646-4650, 1988, "Contrasting Actions of Staurosporine, A protein Kinase C Inhibitor, on Human Neutrophils and Primary Mouse Epidermal Cells".
Shepherd, "The Synaptic Organization of the Brain" Second Edition, pp. 308-314 (Oxford University Press, New York, 1979).
Siman et al., Neuron 1:279-287, 1988, "Excitatory Amino Acids Activate Calpain I and Induce Structural Protein Breakdown in vivo".
Smith et al., Biochem. and Biophys. Research Communications 152:1497-1503, 1988, "Effects of a Protein Kinase C Inhibitor, K-252A, On Human Polymorphonuclear Neutrophil Responsiveness".
Steglich et al., Angew. Chem. Int. Ed. Engl. 19:459-460, 1980, "Indole Pigments from the Fruiting Bodies of the Slime Mold Arcyria Denudata".
Tischler et al., The Journal of Biological Chemistry 266:1141-1146, 1991, "A Protein Kinase Inhibitor, Staurosporine, Mimics Nerve Growth Factor Induction of Neurotensin/Neuromedin N Gene Expression".
Vitullo, Press Release "Cephalon and Kyowa Hakko Co., Ltd. Announce Collaboration," Jun. 2, 1992.
Wolf et al., Biochem. and Biophys. Research Communications 154:1273-1279, 1988, "The Protein Kinase Inhibitor Staurosporine, Like Phorbol Esters, Induces the Association of Protein Kinase C with Membranes".
Hirata, Chemical Abstracts, vol. 107, Issued 1987, Jul. 10, 1987 Abstract No. 236750y.
Hirata et al., Chemical Abstracts, vol. 107, Issued 1987, Abstract No. 2367512, Jul. 10, 1987.
Hirata et al., Chemical Abstracts, vol. 111, Issued 1989, Abstract No. 194456g (Dec. 1, 1988).
Akiyama et al., Chemical Abstracts, vol. 107, Issued 1987, Abstract No. 197943 (Jun. 1, 1987).

Affiliated with

Also associated with

Rating

Selected protein kinase inhibitors for the treatment of neurolog does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Selected protein kinase inhibitors for the treatment of neurolog, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selected protein kinase inhibitors for the treatment of neurolog will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1887618